In conclusion, the NAVETA Obesity Consensus Tool provides the first consensus-based framework in Spain for the standardized and patient-centered assessment of individuals living with obesity, particularly in the context of pharmacological treatment with GLP-1 receptor agonists. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.